colorectal cancer

New research published in Plos Medicine links prolonged sedentary behavior to a 9% higher risk of cancer death, with strong associations to leukemia, kidney, liver, and colorectal cancers. The study, involving 91,000 U.K. Biobank participants, found that uninterrupted sedentary time of at least 30 minutes increases risks, even for physically active individuals.

GLP-1 receptor agonists, including Ozempic, show potential in reducing cancer risk through weight loss, inflammation reduction, and metabolic improvements. Early studies link their use to a 30-35% lower breast cancer incidence in women and reduced risks for colorectal, endometrial, ovarian, liver, and brain cancers.

A new discovery related to colorectal cancer suggests a potential for earlier diagnosis. The article highlights the suspected link between gut microbiomes and the development of colorectal cancer.

A former UNC basketball champion was arrested as part of an illegal sports betting scheme involving six people. A Charlotte medical student is biking 4,000 miles across the U.S. to raise colorectal cancer awareness. A 'catastrophic' wastewater spill released 6,000 gallons into a North Carolina lake, closing a swimming area. Extreme heat is expected for the Fourth of July weekend, with temperatures reaching 100 degrees in Charlotte.

Colorectal cancer is increasingly affecting younger adults in the U.S. and Washington. Seattle researchers are investigating whether environmental exposures might contribute to this trend.

Early-onset cancers, including colorectal and breast cancers, are rising in U.S. adults under 50. Family history is a critical risk factor, and early screenings can save lives, as demonstrated by Bryce Ramsey’s stage 3 colon cancer diagnosis at 33 and her family’s subsequent diagnoses.

Amy Piccoli was diagnosed with late-stage colorectal cancer during a chance emergency room visit. An innovative surgery saved her life.

A new study on the pancreatic cancer drug daraxonrasib shows it could double survival rates for over 90% of patients. Researchers are investigating its potential effectiveness in lung, ovarian, and colorectal cancers.

A new study found that GLP-1 weight-loss medications may slow the spread of several obesity-related cancers, including breast, prostate, lung, colorectal, and liver cancers.

The American Cancer Society updated its colorectal cancer screening guidelines, recommending adults start screenings at age 45 and include blood-based tests as an option. This change aims to address rising cancer rates in younger populations.

The American Cancer Society updated colorectal cancer screening guidelines, recommending adults at average risk start screening at age 45 and offering blood-based tests and at-home options. The changes aim to address rising cases in younger adults and improve early detection, with studies showing a 50% increase in diagnoses among 45-49-year-olds from 2021 to 2022.

The American Cancer Society updated its colorectal cancer screening guidelines to include a first-ever blood test as a new option. Adults are still advised to undergo colonoscopy tests every 10 years starting at age 45 and ending at 75.

A new blood test for colorectal cancer has been added to the American Cancer Society's recommended screenings. It serves as an alternative to colonoscopies, aiming to increase screening rates among people who might not otherwise get tested.

Dr. Céline Gounder discusses the American Cancer Society's updated guidelines for colorectal cancer screenings on 'CBS Mornings'. The guidelines aim to improve early detection and prevention strategies.

The American Cancer Society has included Guardant Health's Shield blood test as a new option for colorectal cancer screening. This addition expands non-invasive testing methods for early cancer detection.

The article examines whether colorectal cancer (CRC) rates are increasing among young people, citing data suggesting a concerning trend. It highlights potential contributing factors like lifestyle and dietary changes.

Colorectal cancer diagnoses are increasing in adults under 50, with cases appearing in people as young as their thirties, often without family history or warning signs. A Swiss study tracking nearly 100,000 cases over four decades found steadily rising rates in younger patients while rates decline in older adults due to screening programs. Younger patients face delayed diagnoses, with cancer often detected after it has already spread.

A UK-led trial has shown promising results for colorectal cancer treatment using pembrolizumab immunotherapy before surgery, keeping patients cancer-free for nearly three years. This approach challenges the standard method of surgery followed by months of chemotherapy. Patients received just nine weeks of pembrolizumab prior to surgery.

Colorectal cancer is highly treatable when detected early, but younger adults rarely undergo screening. Patient advocates are urging open conversations with doctors about risk factors and bowel movements to improve early detection rates.

Colorectal cancer is becoming more lethal for younger people, prompting scientists to investigate the microbiome for potential causes. Researchers are analyzing how changes in gut bacteria might contribute to this rising trend.

Rectal cancer deaths are rising rapidly among millennials, prompting concerns about a medical crisis. The American Cancer Society now recommends colorectal cancer screening starting at age 45 for average-risk individuals, with follow-up colonoscopies every 10 years if initial results are normal.

A newly discovered virus within a common gut bacterium may explain how a microbe present in both healthy individuals and cancer patients is linked to colorectal cancer. The research highlights the role of bacteria-virus interactions in disease risk and suggests potential future screening tests for early cancer detection.

Colorectal cancer deaths are rising among younger adults without college degrees, with mortality rates increasing from 4.0 to 5.2 per 100,000 for those with high school education or less, while remaining stable at 2.7 per 100,000 for college graduates. The study attributes this disparity to socioeconomic factors like obesity, physical inactivity, smoking, and diet, rather than education itself.

A study published in JAMA Oncology found that rising colorectal cancer deaths in younger adults (ages 25-49) are concentrated among those without a four-year college degree. Socioeconomic factors like lower income, poorer diets, and reduced medical care are linked to the disparity, with death rates increasing from 3 to 4 per 100,000 for this group, compared to stable rates for those with bachelor's degrees.

The article discusses growing calls for lowering cancer screening ages in several countries for breast, colorectal, and other cancers. Scientists caution that expanding screening may lead to more harm than benefit due to potential risks and limitations.

The study reveals that metastasis-associated oncofetal cell states appear in early colorectal cancers, with spatial profiling showing fibroblast subtypes resembling normal tissue architecture. These distinct regional microenvironments influence the timing and positioning of oncofetal plasticity, offering new insights into cancer progression mechanisms.

A new stool test using AI and microbiome research detects 90% of colorectal cancers, potentially replacing traditional colonoscopies. The method identifies cancer through subtle gut bacterial patterns, offering a non-invasive alternative to existing diagnostic tools.